Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase).
Boveda S, Garcia R, Defaye P, Piot O, Narayanan K, Barra S, Gras D, Providencia R, Algalarrondo V, Beganton F, Perier MC, Jacob S, Bordachar P, Babuty D, Klug D, Leclercq C, Fauchier L, Sadoul N, Deharo JC, Marijon E; DAI-PP investigators.
Boveda S, et al. Among authors: marijon e.
Arch Cardiovasc Dis. 2019 Aug-Sep;112(8-9):523-531. doi: 10.1016/j.acvd.2019.05.005. Epub 2019 Aug 27.
Arch Cardiovasc Dis. 2019.
PMID: 31471226
Free article.
Review.